Logo image of DRTT

DIRTT ENVIRONMENTAL SOLUTION (DRTT) Stock Fundamental Analysis

NASDAQ:DRTT - Nasdaq - CA25490H1064 - Common Stock - Currency: USD

0.3343  0 (-0.36%)

After market: 0.2849 -0.05 (-14.78%)

Fundamental Rating

1

Overall DRTT gets a fundamental rating of 1 out of 10. We evaluated DRTT against 42 industry peers in the Building Products industry. DRTT has a bad profitability rating. Also its financial health evaluation is rather negative. DRTT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year DRTT has reported negative net income.
In the past year DRTT has reported a negative cash flow from operations.
In the past 5 years DRTT reported 4 times negative net income.
In multiple years DRTT reported negative operating cash flow during the last 5 years.
DRTT Yearly Net Income VS EBIT VS OCF VS FCFDRTT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M -40M -60M

1.2 Ratios

DRTT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DRTT Yearly ROA, ROE, ROICDRTT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300

1.3 Margins

DRTT's Gross Margin of 19.67% is on the low side compared to the rest of the industry. DRTT is outperformed by 75.56% of its industry peers.
DRTT's Gross Margin has declined in the last couple of years.
DRTT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.31%
GM growth 5Y-17.09%
DRTT Yearly Profit, Operating, Gross MarginsDRTT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40

0

2. Health

2.1 Basic Checks

DRTT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DRTT has been increased compared to 1 year ago.
The debt/assets ratio for DRTT is higher compared to a year ago.
DRTT Yearly Shares OutstandingDRTT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
DRTT Yearly Total Debt VS Total AssetsDRTT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

DRTT has an Altman-Z score of -1.12. This is a bad value and indicates that DRTT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DRTT (-1.12) is worse than 93.33% of its industry peers.
DRTT has a Debt/Equity ratio of 8.35. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of DRTT (8.35) is worse than 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.35
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACC8.43%
DRTT Yearly LT Debt VS Equity VS FCFDRTT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.51 indicates that DRTT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.51, DRTT is not doing good in the industry: 82.22% of the companies in the same industry are doing better.
DRTT has a Quick Ratio of 1.51. This is a bad value and indicates that DRTT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DRTT (0.89) is worse than 82.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.89
DRTT Yearly Current Assets VS Current LiabilitesDRTT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

DRTT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.97%, which is quite impressive.
DRTT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.06%.
Measured over the past years, DRTT shows a decrease in Revenue. The Revenue has been decreasing by -5.31% on average per year.
EPS 1Y (TTM)35.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
Revenue 1Y (TTM)9.06%
Revenue growth 3Y-11.42%
Revenue growth 5Y-5.31%
Sales Q2Q%-4.12%

3.2 Future

The Earnings Per Share is expected to grow by 35.11% on average over the next years. This is a very strong growth
Based on estimates for the next years, DRTT will show a small growth in Revenue. The Revenue will grow by 2.38% on average per year.
EPS Next Y65.08%
EPS Next 2Y35.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.82%
Revenue Next 2Y2.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DRTT Yearly Revenue VS EstimatesDRTT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
DRTT Yearly EPS VS EstimatesDRTT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -0.2 -0.4 -0.6

1

4. Valuation

4.1 Price/Earnings Ratio

DRTT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DRTT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRTT Price Earnings VS Forward Price EarningsDRTT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRTT Per share dataDRTT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as DRTT's earnings are expected to grow with 35.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.11%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DRTT!.
Industry RankSector Rank
Dividend Yield N/A

DIRTT ENVIRONMENTAL SOLUTION

NASDAQ:DRTT (9/14/2023, 9:21:28 PM)

After market: 0.2849 -0.05 (-14.78%)

0.3343

0 (-0.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-03 2023-08-03/bmo
Earnings (Next)11-13 2023-11-13/amc
Inst Owners60.19%
Inst Owner ChangeN/A
Ins Owners8%
Ins Owner Change0%
Market Cap34.92M
Analysts80
Price Target1.42 (324.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.73%
Min EPS beat(2)-69.73%
Max EPS beat(2)-69.73%
EPS beat(4)1
Avg EPS beat(4)-10.01%
Min EPS beat(4)-69.73%
Max EPS beat(4)43.42%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.27%
Min Revenue beat(2)-9.54%
Max Revenue beat(2)-0.99%
Revenue beat(4)1
Avg Revenue beat(4)-2.47%
Min Revenue beat(4)-9.54%
Max Revenue beat(4)1.98%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 4.73
P/tB 12.2
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS1.63
BVpS0.07
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.67%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.31%
GM growth 5Y-17.09%
F-Score3
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 8.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.63%
Cap/Sales 2.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.89
Altman-Z -1.12
F-Score3
WACC8.43%
ROIC/WACCN/A
Cap/Depr(3y)100.77%
Cap/Depr(5y)107.1%
Cap/Sales(3y)8.08%
Cap/Sales(5y)7.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.56%
EPS Next Y65.08%
EPS Next 2Y35.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.06%
Revenue growth 3Y-11.42%
Revenue growth 5Y-5.31%
Sales Q2Q%-4.12%
Revenue Next Year-2.82%
Revenue Next 2Y2.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2359.14%
OCF growth 3YN/A
OCF growth 5YN/A